⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6085543 | 0.97 | — | — | |
| SCHEMBL112025 | 0.94 | — | — | |
| SCHEMBL1190965 | 0.88 | — | — | |
| SCHEMBL18763507 | 0.87 | — | — | |
| SCHEMBL2639734 | 0.87 | — | — | |
| SCHEMBL1267677 | 0.85 | — | — | |
| SCHEMBL15556892 | 0.83 | — | — | |
| SCHEMBL4804534 | 0.81 | — | — | |
| SCHEMBL2992030 | 0.81 | — | — | |
| SCHEMBL439890 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 465 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100298402-A1 | STILBENE DERIVATIVES AS PSTAT3/IL-6 INHIBITORS | ORCHID RESEARCH LABORATORIES LIMITED (IN) | 2010-11-25 | — | — | US | claimed |
| US-20240240047-A1 | BIOMEDICAL DEVICES HAVING A SURFACE COATING | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT | 2024-07-18 | — | — | US | disclosed |
| WO-2024146878-A1 | BIOMEDICAL DEVICES HAVING A SURFACE COATING | BAUSCH + LOMB IRELAND LIMITED (IE) | 2024-07-11 | — | — | WO | disclosed |
| EP-4396616-A1 | OPHTHALMIC DEVICES | Bausch + Lomb Ireland Limited (IE) | 2024-07-10 | — | — | EP | disclosed |
| EP-4396626-A1 | OPHTHALMIC DEVICES AND METHOD OF MANUFACTURING | Bausch + Lomb Ireland Limited (IE) | 2024-07-10 | — | — | EP | disclosed |
| EP-4396627-A1 | OPHTHALMIC DEVICES AND METHOD OF MANUFACTURING | Bausch + Lomb Ireland Limited (IE) | 2024-07-10 | — | — | EP | disclosed |
| CN-112930487-B | Ophthalmic device | 鲍希与洛姆伯股份有限公司 | 2024-07-02 | — | — | CN | disclosed |
| EP-3917837-B1 | PACKAGING SOLUTIONS FOR CONTACT LENSES | BAUSCH & LOMB (US) | 2024-06-26 | — | — | EP | disclosed |
| US-20240197747-A1 | TREATMENT OF VIRAL INFECTIONS WITH COMBINATION OF PIKFYVE KINASE INHIBITORS AND TMPRSS-2 INHIBITORS | AcuraStem, Inc. (US) | 2024-06-20 | — | — | US | disclosed |
| EP-4367123-A1 | PYRIMIDINE COMPOUNDS FOR USE AS MAP4K1 INHIBITORS | Glenmark Specialty S.A. (CH) | 2024-05-15 | — | — | EP | disclosed |
| EP-1674484-A2 | Process for the solid phase synthesis of aldehydes, ketones, oximes, amines and hydroxamic acid componds | Aventis Pharmaceuticals Products Inc. (US) | 2006-06-28 | — | — | EP | disclosed |
| US-20050090501-A1 | Heteroaryl-cyclic acetals | AVENTIS PHARMA LIMITED (GB) | 2005-04-28 | — | — | US | disclosed |
| EP-0960096-B1 | SUBSTITUTED BETA-THIOCARBOXYLIC ACIDS | AVENTIS PHARMA INC (US) | 2005-04-06 | — | — | EP | disclosed |
| EP-1486486-A2 | Substituted B-thiocarboxylic acids | Aventis Pharmaceuticals Inc. (US) | 2004-12-15 | — | — | EP | disclosed |
| EP-0946478-A4 | PROCESS FOR THE SOLID PHASE SYNTHESIS OF ALDEHYDES, KETONES, OXIMES, AMINES AND HYDROXAMIC ACID COMPOUNDS | AVENTIS PHARM PROD INC (US) | 2004-09-08 | — | — | EP | disclosed |
| US-6306873-B1 | Substituted β-thiocarboxylic acids | AVENTIS PHARMACEUTICALS PRODUCTS INC. | 2001-10-23 | — | — | US | disclosed |
| EP-0960096-A1 | SUBSTITUTED $g(b)-THIOCARBOXYLIC ACIDS | RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) | 1999-12-01 | — | — | EP | disclosed |
| EP-0946478-A1 | PROCESS FOR THE SOLID PHASE SYNTHESIS OF ALDEHYDES, KETONES, OXIMES, AMINES AND HYDROXAMIC ACID COMPOUNDS | RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) | 1999-10-06 | — | — | EP | disclosed |
| WO-1998032734-A1 | SUBSTITUTED β-THIOCARBOXYLIC ACIDS | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1998-07-30 | — | — | WO | disclosed |
| WO-1998029376-A1 | PROCESS FOR THE SOLID PHASE SYNTHESIS OF ALDEHYDES, KETONES, OXIMES, AMINES AND HYDROXAMIC ACID COMPOUNDS | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1998-07-09 | — | — | WO | disclosed |